These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34718110)

  • 1. Diabetes insipidus.
    Christ-Crain M; Gaisl O
    Presse Med; 2021 Dec; 50(4):104093. PubMed ID: 34718110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.
    Pedrosa W; Drummond JB; Soares BS; Ribeiro-Oliveira A
    Endocr Pract; 2018 Nov; 24(11):963-972. PubMed ID: 30106630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational diabetes insipidus: Diagnosis and management.
    Ananthakrishnan S
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach.
    Vergier J; Fromonot J; Alvares De Azevedo Macedo A; Godefroy A; Marquant E; Guieu R; Tsimaratos M; Reynaud R
    Arch Pediatr; 2018 Jan; 25(1):45-47. PubMed ID: 29241593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.
    Timper K; Fenske W; Kühn F; Frech N; Arici B; Rutishauser J; Kopp P; Allolio B; Stettler C; Müller B; Katan M; Christ-Crain M
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2268-74. PubMed ID: 25768671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of diabetes insipidus for the internist: an update.
    Christ-Crain M; Winzeler B; Refardt J
    J Intern Med; 2021 Jul; 290(1):73-87. PubMed ID: 33713498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
    Atila C; Refardt J; Christ-Crain M
    Nat Rev Endocrinol; 2024 Aug; 20(8):487-500. PubMed ID: 38693275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes insipidus.
    Christ-Crain M; Bichet DG; Fenske WK; Goldman MB; Rittig S; Verbalis JG; Verkman AS
    Nat Rev Dis Primers; 2019 Aug; 5(1):54. PubMed ID: 31395885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome.
    Trimpou P; Olsson DS; Ehn O; Ragnarsson O
    Hormones (Athens); 2017 Oct; 16(4):414-422. PubMed ID: 29518762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests.
    Fenske W; Quinkler M; Lorenz D; Zopf K; Haagen U; Papassotiriou J; Pfeiffer AF; Fassnacht M; Störk S; Allolio B
    J Clin Endocrinol Metab; 2011 May; 96(5):1506-15. PubMed ID: 21367924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial forms of diabetes insipidus: clinical and molecular characteristics.
    Babey M; Kopp P; Robertson GL
    Nat Rev Endocrinol; 2011 Jul; 7(12):701-14. PubMed ID: 21727914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome.
    Christ-Crain M
    Eur J Endocrinol; 2019 Jul; 181(1):R11-R21. PubMed ID: 31067508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyuria-polydipsia syndrome: a diagnostic challenge.
    Nigro N; Grossmann M; Chiang C; Inder WJ
    Intern Med J; 2018 Mar; 48(3):244-253. PubMed ID: 28967192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
    Fenske W; Refardt J; Chifu I; Schnyder I; Winzeler B; Drummond J; Ribeiro-Oliveira A; Drescher T; Bilz S; Vogt DR; Malzahn U; Kroiss M; Christ E; Henzen C; Fischli S; Tönjes A; Mueller B; Schopohl J; Flitsch J; Brabant G; Fassnacht M; Christ-Crain M
    N Engl J Med; 2018 Aug; 379(5):428-439. PubMed ID: 30067922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
    Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin in the differential diagnosis of hypotonic polyuria.
    Christ-Crain M; Fenske WK
    J Endocrinol Invest; 2020 Jan; 43(1):21-30. PubMed ID: 31368050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes insipidus.
    Leroy C; Karrouz W; Douillard C; Do Cao C; Cortet C; Wémeau JL; Vantyghem MC
    Ann Endocrinol (Paris); 2013 Dec; 74(5-6):496-507. PubMed ID: 24286605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.